Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid
about
Niacin Alternatives for Dyslipidemia: Fool's Gold or Gold Mine? Part II: Novel Niacin MimeticsNiacin, an old drug with a new twistThe therapeutic role of niacin in dyslipidemia managementThe Effects of Niacin on Inflammation in Patients with Non-ST Elevated Acute Coronary SyndromePrioritizing Environmental Chemicals for Obesity and Diabetes Outcomes Research: A Screening Approach Using ToxCast™ High-Throughput DataNiacin in pharmacological doses alters microRNA expression in skeletal muscle of obese Zucker rats.NAFLD Susceptibility Genes and their Association with Type 2 Diabetes and Obesity in a New Mexico Population.Extended-release niacin acutely suppresses postprandial triglyceridemia.PGC-1 coactivators in the control of energy metabolism.Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug.Circadian metabolic regulation through crosstalk between casein kinase 1δ and transcriptional coactivator PGC-1α.Ocular Effects of Niacin: A Review of the Literature.Transcriptional control of circadian metabolic rhythms in the liver.The Liver Clock Controls Cholesterol Homeostasis through Trib1 Protein-mediated Regulation of PCSK9/Low Density Lipoprotein Receptor (LDLR) Axis.Peroxisome proliferator-activated receptor γ coactivator 1β (PGC-1β) protein attenuates vascular lesion formation by inhibition of chromatin loading of minichromosome maintenance complex in smooth muscle cellsDiagnosis and treatment of severe hypertriglyceridemia.Nicotinic acid: clinical considerations.The regulation of ApoB metabolism by insulin.Hyperlipoproteinemia type 3: the forgotten phenotype.Niacin as antidyslipidemic drug.Targeting ApoC-III to Reduce Coronary Disease Risk.Is hepatic lipogenesis fundamental for NAFLD/NASH? A focus on the nuclear receptor coactivator PGC-1β.A Novel Role for RARα Agonists as Apolipoprotein CIII Inhibitors Identified from High Throughput Screening.Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04.Niacin: the only vitamin that reduces cardiovascular events.Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitis.Zbtb7b engages the long noncoding RNA Blnc1 to drive brown and beige fat development and thermogenesis.NRG1-Fc improves metabolic health via dual hepatic and central action.Postprandial effects of long-term niacin/laropiprant use on glucose and lipid metabolism and on cardiovascular risk in patients with polycystic ovary syndrome.γ-Secretase Inhibition Lowers Plasma Triglyceride-Rich Lipoproteins by Stabilizing the LDL Receptor.Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites
P2860
Q26765137-299443D8-94C8-435D-8CEE-57A5F60C0AC7Q27002774-6FD773E8-72E8-4ECE-B733-F6084A2D2D82Q28304559-DE079F37-BDB6-4E65-8B60-75DE49857220Q28468704-4AB9A40E-32EC-4B34-A084-BC987B90EE11Q28831114-F8D2312F-4AF4-4545-BB13-4A0A959DA2BDQ33646129-8E0BF689-5214-4436-9B42-F57F2D1D65D5Q33768820-715EACC3-56B6-447A-86EB-7D325F7AB43CQ34223452-018E3F8A-C886-420D-A8FC-6933FC3B34E4Q34712077-6EDAE93B-4272-4D3D-8DE2-394D31671F3BQ35432791-C81AD5EF-5BA2-4D77-ADD5-1662F40DAB53Q35595707-F05C5731-C624-43AB-A780-E497F7A776CAQ35690848-B7803E0C-F207-428A-A2C5-09B46B7DE01DQ36034647-D065B3CF-3067-4FB9-BC8B-433BD5EF607DQ36407293-2193305B-E37C-4E43-AC7E-DCDE03FB2A03Q36620705-3E9758CD-DBC8-4BEF-9796-350B70658ED3Q37998115-06B16955-6BAC-48E9-B815-B533696C39C0Q38008035-73FDEFC1-F890-4634-B8F8-DF326E89EDF0Q38110665-292D4C58-8074-4961-AFF8-E90FE181AC97Q38235600-F32E862C-1FE8-4226-9504-61D9B2658067Q38586930-DB90E3A0-8718-4966-BCAE-0361D44DCE38Q38904497-510A4DFF-0446-42E7-A845-170916F8A85AQ38927251-706E4CC8-4966-4AD6-AC11-8850234D739DQ41063014-87A9337E-E1D2-4277-9168-B4BE77EBC319Q41411846-89E0F47D-D1C3-4D25-9619-B3C61BD75057Q44004071-6FFA9A2D-A68E-464B-B044-3BC692635901Q45952314-E4D97671-3DDA-4B8D-810B-0E7DAE5BDB5CQ47809174-30FB42CF-B4AF-4A8B-B030-1992A315A4A8Q50420465-0E23654E-80C4-43E2-8F08-874687EE502EQ51328922-575C49AD-A14C-4ED2-9741-8DC737D3ABDBQ51735096-D87FD25C-01E0-465C-970F-D284E1931B4BQ57568837-488E901D-B55D-4326-9F38-B68C9C22EE85
P2860
Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@ast
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@en
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@nl
type
label
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@ast
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@en
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@nl
prefLabel
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@ast
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@en
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@nl
P2093
P2860
P3181
P1433
P1476
Regulation of hepatic ApoC3 ex ...... demic effect of nicotinic acid
@en
P2093
Jiandie D Lin
Matthew Molusky
Yaqiang Li
P2860
P304
P3181
P356
10.1016/J.CMET.2010.09.001
P407
P577
2010-10-01T00:00:00Z